Skip to content
value.today

Allakos Inc.

🇺🇸 San Mateo, California, USAPharmaceuticalsFounded 2012
Total raised
$128 M
2 rounds on record
Latest round
$100 M
Nov 2017
First round on record
Dec 2012
Today
Private
No later event on record

Funding rounds

2 counted as startup funding. Open the number of investors for the round's details.

Funding rounds of Allakos Inc.
MonthRaisedRaiseSizeInvestorsSoldFiling
Nov 2017$100 MNo. 2$50 to $250 million

Allakos Inc.: Raise no. 2, Nov 2017

Investors in this round

40 investors had bought by the notice of Dec 18, 2017: 40 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round. 13 investors are named for Allakos Inc. as a whole in other filings: see Investors below.

What the notice says

Amount sold
$100 M of $100 M offered
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Adam Tomasi · Executive Officer
  • Robert Alexander · Executive Officer, Director
  • Dan Janney · Director
  • John McKearn · Director
  • Paul Walker · Director
  • Steve James · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Robert Alexander, President and CEO. Source: SEC Form D, newest notice filed Dec 18, 2017. Read the notice at the SEC.

equitySEC
Dec 2012$28 MNo. 1$10 to $50 million

Allakos Inc.: Raise no. 1, Dec 2012

Investors in this round

12 investors had bought by the notice of Mar 25, 2015: 12 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round. 13 investors are named for Allakos Inc. as a whole in other filings: see Investors below.

What the notice says

Amount sold
$28 M of $47 M offered; $19 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
more than a year
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Alejandro Dorenbaum · Executive Officer
  • Christopher Bebbington · Executive Officer, Director
  • Nenad Tomasevic · Executive Officer
  • Farah Champsi · Director
  • John McKearn · Director
  • Peter Moldt · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Christopher Bebbington, President & CEO. Source: SEC Form D and 2 amendments, newest notice filed Mar 25, 2015. Read the notice at the SEC.

equitySEC

Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.

How it makes money#

What its filings and its own website say, sentence by sentence, each with its source.

  • Allakos Inc. chose not to state its revenue in its newest notice of a funding round (Dec 2017).

    SEC Form D · Dec 2017

  • The industry group it chose in its notices: Pharmaceuticals.

    SEC Form D · Dec 2017

That is all the official record says: Allakos Inc. has not published its revenue in a filing we can read, and no other official source covers it. Revenue figures come from crowdfunding filings (SEC Form C) and from annual reports once a company is listed.

Products and services#

No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).

Investors#

13 named in official filings. Open an investor to see everything it has backed.

Investors in Allakos Inc.
InvestorKindAmountRoundRoleSource
3x5 RiverVest Fund II-B, L.P.Fund or asset managernot statednot statedHeld Series A and B preferred stock, 10% owner (Form 3, 2018)SEC Form 3
3x5 RiverVest Fund II, L.P.Fund or asset managernot statednot statedHeld Series A and B preferred stock, 10% owner (Form 3, 2018)SEC Form 3
Alta Partners Management VIII, LLCFund or asset managernot statednot statedHeld Series A and B preferred stock, 10% owner (Form 3, 2018)SEC Form 3
Alta Partners NextGen Fund I, L.P.Fund or asset managernot statednot statedHeld Series A and B preferred stock, 10% owner (Form 3, 2018)SEC Form 3
Alta Partners NextGen Fund I Management, LLCFund or asset managernot statednot statedHeld Series A and B preferred stock, 10% owner (Form 3, 2018)SEC Form 3
Alta Partners VIII, L.P.Fund or asset managernot statednot statedHeld Series A and B preferred stock, 10% owner (Form 3, 2018)SEC Form 3
Redmile Group, LLCFund or asset managernot statednot statedHeld Series B preferred stock, 10% owner (Form 3, 2018)SEC Form 3
RiverVest Venture Fund III, L.P.Venture capitalnot statednot statedHeld Series A and B preferred stock, 10% owner (Form 3, 2018)SEC Form 3
RiverVest Venture Fund III (Ohio), L.P.Venture capitalnot statednot statedHeld Series A and B preferred stock, 10% owner (Form 3, 2018)SEC Form 3
Rivervest Venture Fund II L.P.Venture capitalnot statednot statedHeld Series A and B preferred stock, 10% owner (Form 3, 2018)SEC Form 3
RiverVest Venture Fund II (Ohio), L.P.Venture capitalnot statednot statedHeld Series A and B preferred stock, 10% owner (Form 3, 2018)SEC Form 3
Roche Finance LTDCompanynot statednot statedHeld Series A and B preferred stock, 10% owner (Form 3, 2018)SEC Form 3
Roche Holding LTDCompanynot statednot statedHeld Series A and B preferred stock, 10% owner (Form 3, 2018)SEC Form 3

Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete: the 2 rounds above had up to 40 investors.

Executives and directors

As the company named them in its notices. Directors of a funded startup are often partners of its investors.

People named by Allakos Inc.
NameRoleNamed in
Adam TomasiExecutive officerDec 2017
Robert AlexanderExecutive officerDec 2017
Alejandro DorenbaumExecutive officerMar 2015
Christopher BebbingtonExecutive officerMar 2015
Nenad TomasevicExecutive officerMar 2015
Dan JanneyDirectorDec 2017
John McKearnDirectorDec 2017
Paul WalkerDirectorDec 2017
Robert AlexanderDirectorDec 2017
Steve JamesDirectorDec 2017
Christopher BebbingtonDirectorMar 2015
Farah ChampsiDirectorMar 2015
Peter MoldtDirectorMar 2015